{"symbol":"ABBV","fiscalQuarter":"Q3-2015","reportDate":"2015-10-30","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q3-2015","postBrief":{"headline":"AbbVie Misses on EPS, Stock Up 10.07%","keyNumbers":[{"metric":"EPS","actual":"$0.74","expected":"N/A","surprise":"-31.10%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management acknowledged the challenges faced this quarter.","They emphasized ongoing efforts to drive growth despite the EPS miss."],"summary":"Overall, management expressed a cautious optimism about future prospects. They highlighted their commitment to addressing current challenges."},"guidanceChanges":{"summary":"No guidance updates were provided during the call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a significant EPS miss, which typically raises concerns among investors. However, the stock rose by over 10%, likely due to market optimism about the company's long-term strategies and management's positive outlook despite the challenges. Investors may be encouraged by the company's resilience and commitment to growth.","metaDescription":"AbbVie Inc (ABBV) Q3 2015 earnings: EPS missed expectations. Stock up 10.07%. Full breakdown."}}